Oral LAT8881 in Neuropathic Pain

Clinical trial NCT03865953 · COMPLETED

Trial details

NCT number: NCT03865953
Sponsor: Lateral Pharma Pty Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuropathic Pain Diabetic Peripheral Neuropathy (DPN)Post Herpetic Neuralgia (PHN)

Start date: 2019-04-09
Primary completion: 2020-04-19
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.